David Cahn

Fox Chase Cancer Center, Philadelphia University

Papers

3

Total Citations

26

H-Index

2

About

David Cahn is a urologic surgeon and researcher whose work focuses on advancing minimally invasive surgical techniques for complex urologic conditions, with particular expertise in robotic-assisted surgery for kidney and bladder cancers. His most cited study, "Safety and early effectiveness of robot‐assisted partial nephrectomy for large angiomyolipomas" (18 citations), demonstrated the feasibility and safety of robotic nephron-sparing surgery for large renal angiomyolipomas across five academic centers, helping to establish robotic partial nephrectomy as a viable alternative to more invasive approaches. Cahn has also made important contributions to understanding postoperative complications in bladder cancer surgery; his work on incisional hernia after cystectomy (6 citations) identified key risk factors and anthropometric predispositions, comparing outcomes between open and robotic-assisted approaches. Additionally, his investigation into the clinical significance of indeterminate pulmonary nodules in patients undergoing radical cystectomy for urothelial carcinoma (2 citations) has helped guide surveillance strategies for this challenging patient population. Through these studies, Cahn has advanced the evidence base for robotic urologic oncology, improving surgical decision-making and patient outcomes in the management of kidney and bladder malignancies.

Research Focus

Key Achievements

2
H-Index
3
Papers
26
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Safety and early effectiveness of robot‐assisted partial nephrectomy for large angiomyolipomas
18 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: Fox Chase Cancer Center, Philadelphia University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago